Vision and Mission
Our vision is to be the most valuable nuclear medicine company in China, as well as a trusted leader in the world.
Bring hope to patients with the most innovative nuclear medicine diagnostic and therapeutic products.More
Research and Development
Committed to the development, production and commercialization of diagnostic and therapeutic drugs in the field of nuclear medicine.
We have built a series of R&D pipelines for nuclear medicine drugs, including recombinant proteins, radioactive imaging agents, and radiotherapeutic drugs.
- Recombinant protein
- Radioisotope targeted imaging
- Radioisotope targeted therapy
PD-L1/CD8+T Cell Contrast Agent
An innovative radionuclide contrast agent drug based on single-domain antibody, real-time, non-invasive and dynamic visualization of the expression level of target targets throughout the body
- PD-L1 radioactive contrast agent(SNA002)
- CD8+ T cell contrast agent(SNA006)